135N.2  Legislative intent and findings.
  1.  It is the intent of the general assembly to establish an advisory committee to provide recommendations on cost-effective treatment programs that enhance the quality of life of those afflicted with hemophilia and contain the high cost of that treatment.
  2.  The general assembly finds inherited hemophilia and other bleeding and clotting disorders are devastating health conditions that can cause serious financial, social, and emotional hardships for patients and their families. Hemophilia and other bleeding and clotting disorders are incurable, so appropriate lifetime care and treatment are necessities for maintaining optimum health. Advancements in drug therapies are allowing individuals greater latitude in managing their conditions, fostering independence, and minimizing chronic complications. However, the rarity of these disorders coupled with the delicate processes for producing factors and administering anticoagulants makes treating these disorders extremely costly.
2007 Acts, ch 31, §2, 7